Jennifer B. Dennison

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1.1K citations

Medicine, Oncology, Pharmacology +16

Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models

Jae‐Ho Cheong, Eun Sung Park, Jiyong Liang et al. · Molecular Cancer Therapeutics · 2011 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Julia Billiard, Jennifer B. Dennison, Jacques Briand et al. · Cancer & Metabolism · 2013 · 238 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection

Johannes F. Fahrmann, C. Max Schmidt, Xiangying Mao et al. · Gastroenterology · 2020 · 201 citations · Full text

Medicine, Oncology, Pathology +14

SELECTIVE METABOLISM OF VINCRISTINE IN VITRO BY CYP3A5

Jennifer B. Dennison, Palaniappan Kulanthaivel, Robert J. Barbuch et al. · Drug Metabolism and Disposition · 2006 · 171 citations

Medicine, Pharmacokinetics, Pharmacology +17